CD4 and ovarian carcinoma: Wang et al. found that abnormal expression of CD4 T cell subsets in peripheral blood of patients with ovarian cancer and an imbalance of Th1/Th2 and Treg/Th17 provide a basis for clinical immunotherapy of ovarian cancer [33].